Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study

• Published in: Korean journal of ophthalmology Vol. 31; no. 4; pp. 306 - 312
• Main Authors: Lee, Kwan Bok, Koh, Kyung Min, Kwon, Young A, Song, Sang Wroul, Kim, Byoung Yeop, Chung, Jae Lim
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Ophthalmological Society 01-08-2017; 대한안과학회
• Subjects: Adult; Anterior Eye Segment - diagnostic imaging; Dose-Response Relationship, Drug; Dry Eye Syndromes - diagnosis; Dry Eye Syndromes - drug therapy; Dry Eye Syndromes - metabolism; Female; Humans; Male; Ophthalmic Solutions - administration & dosage; Original; Polyphosphates - administration & dosage; Tears - metabolism; Tomography, Optical Coherence - methods; Uracil Nucleotides - administration & dosage; 안과학; Tear meniscus; Ophthalmic solutions; Diquafosol; Purinergic P2Y receptor agonists; Tears secretion
• ISSN: 1011-8942; 2092-9382
• DOI: 10.3341/kjo.2016.0056

To evaluate changes in the tear meniscus area and tear meniscus height over time in patients with dry eye syndrome, using anterior segment spectral-domain optical coherence tomography after the instillation of 3% diquafosol ophthalmic solution.
Sixty eyes from 30 patients with mild to moderate dry eye syndrome were included. Tear meniscus images acquired by anterior segment spectral-domain optical coherence tomography were analyzed using National Institutes of Health's image-analysis software (ImageJ 1.44p). Tear meniscus area and tear meniscus height were measured at baseline, 5 minutes, 10 minutes, and 30 minutes after instillation of a drop of diquafosol in one eye and normal saline in the other eye. Changes in ocular surface disease index score, tear film break-up time, corneal staining score by Oxford schema, and meibomian expressibility were also evaluated at baseline, and after 1 week and 1 month of a diquafosol daily regimen.
Sixty eyes from 30 subjects (mean age, 29.3 years; 8 men and 22 women) were included. In eyes receiving diquafosol, tear volume was increased at 5 and 10 minutes compared with baseline. It was also higher than saline instilled eyes at 5, 10, and 30 minutes. Changes in tear volume with respect to baseline were not statistically different after the use of diquafosol for 1 month. Ocular surface disease index score, tear film break-up time, and Oxford cornea stain score were significantly improved after 1 week and 1 month of daily diquafosol instillation, but meibomian expressibility did not change.
Topical diquafosol ophthalmic solution effectively increased tear volume for up to 30 minutes, compared to normal saline in patients with dry eye syndrome.